Comment on "Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry"

被引：0
|
作者：
Seo, Hyun-Min [1 ]
Oh, Se Uk [1 ]
Park, Se Kwang [1 ]
Kim, Joung Soo [1 ]
机构：
[1] Hanyang Univ Guri Hosp, Dept Dermatol, Seoul 11923, South Korea
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
EASI;
D O I：
10.1016/j.jaad.2021.01.102
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E171 / E171
页数：1
相关论文
共 50 条
  • [1] Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry
    Bosma, Angela L.
    de Wijs, Linde E. M.
    Hof, Michel H.
    van Nieuwenhuizen, Beau R.
    Gerbens, Louise A. A.
    Middelkamp-Hup, Maritza A.
    Hijnen, DirkJan
    Spuls, Phyllis, I
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (05) : 1375 - 1384
  • [2] LONG-TERM EFFECTIVENESS AND SAFETY OF TREATMENT WITH DUPILUMAB IN PATIENTS WITH ATOPIC DERMATITIS: RESULTS OF THE TREAT NL (TREATMENT OF ATOPIC ECZEMA, THE NETHERLANDS) REGISTRY
    Bosma, Angela L.
    de Wijs, Linde E. M.
    Hof, Michel H. P.
    van Nieuwenhuizen, Beau R.
    Gerbens, Louise A. A.
    Middelkamp-Hup, Maritza A.
    Hijnen, DirkJan
    Spuls, Phyllis I.
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 55 - 55
  • [3] Response to: "Comment on 'Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'''
    Bosma, Angela L.
    de Wijs, Linde E. M.
    Hof, Michel H.
    Middelkamp-Hup, Beau R. van Nieuwenhui-Maritza A.
    Gerbens, Louise A. A.
    Middelkamp-Hup, Maritza A.
    Hijnen, Dirk-Jan
    Spuls, Phyllis I.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : E173 - E174
  • [4] Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry
    Li, Angelo
    Musters, Annelie H.
    Hyseni, Arienna
    Gerbens, Louise A. A.
    Spuls, Phyllis, I
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (06) : 1012 - 1013
  • [5] TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema
    Bosma, A. L.
    Spuls, P. I.
    Garcia-Doval, I.
    Naldi, L.
    Prieto-Merino, D.
    Tesch, F.
    Apfelbacher, C. J.
    Arents, B. W. M.
    Barbarot, S.
    Baselga, E.
    Deleuran, M.
    Eichenfield, L. F.
    Gerbens, L. A. A.
    Irvine, A. D.
    Manca, A.
    Mendes-Bastos, P.
    Middelkamp-Hup, M. A.
    Roberts, A.
    Seneschal, J.
    Svensson, A.
    Thyssen, J. P.
    Torres, T.
    Vermeulen, F. M.
    Vestergaard, C.
    von Kobyletzki, L. B.
    Wall, D.
    Weidinger, S.
    Schmitt, J.
    Flohr, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (06) : 1423 - 1429
  • [6] Real-world reported adverse events related to systemic immunomodulating therapy in patients with atopic dermatitis: Results from the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry
    Musters, A. H.
    van Lookeren, F. L.
    van der Gang, L. F.
    Middelkamp-Hup, M. A.
    Bosma, A. L.
    Jessurun, N. T.
    Lapeere, H.
    Nguyen, A. L.
    Ouwerkerk, W.
    de Schepper, S.
    Gerbens, L. A. A.
    Spuls, P. I.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024, 38 (03) : 530 - 542
  • [7] Efficacy and safety of long-term treatment with dupilumab for moderate to severe atopic dermatitis
    Ikeda, M.
    Uehara, H.
    Tsuge, M.
    ALLERGY, 2019, 74 : 182 - 182
  • [8] Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults
    Patruno, Cataldo
    Stingeni, Luca
    Hansel, Katharina
    Ferrucci, Silvia Mariel
    Tavecchio, Simona
    Fabbrocini, Gabriella
    Nistico, Steven Paul
    Foti, Caterina
    De Prezzo, Serena
    Napolitano, Maddalena
    DERMATOLOGIC THERAPY, 2020, 33 (03)
  • [9] Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis
    Boesjes, Celeste M.
    Kamphuis, Esme
    de Graaf, Marlies
    Spekhorst, Lotte S.
    Haeck, Inge
    van der Gang, Lian F.
    Loman, Laura
    Zuithoff, Nicolaas P. A.
    Dekkers, Coco
    van der Rijst, Lisa P.
    Romeijn, Geertruida L. E.
    Oosting, Albert J.
    Gostynksi, Antoni
    van Lynden-van Nes, Anneke M. T.
    Tupker, Ron A.
    van Serooskerken, Anne-Moon van Tuyll
    Flinterman, Annebeth
    Politiek, Klaziena
    Touwslager, Wouter R. H.
    Christoffers, Wianda A.
    Stewart, Shiarra M.
    Kamsteeg, Marijke
    Schuttelaar, Marie-Louise A.
    de Bruin-Weller, Marjolein S.
    JAMA DERMATOLOGY, 2024, 160 (10) : 1044 - 1055
  • [10] Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study
    Patruno, Cataldo
    Fabbrocini, Gabriella
    Longo, Giuseppe
    Argenziano, Giuseppe
    Ferrucci, Silvia Mariel
    Stingeni, Luca
    Peris, Ketty
    Ortoncelli, Michela
    Offidani, Annamaria
    Amoruso, Giuseppe Fabrizio
    Talamonti, Marina
    Girolomoni, Giampiero
    Grieco, Teresa
    Iannone, Michela
    Nettis, Eustachio
    Foti, Caterina
    Rongioletti, Franco
    Corazza, Monica
    Veneri, Michele Delli
    Napolitano, Maddalena
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (04) : 581 - 586
12345